Loading

International
Biotechnology and Research Conference

April 25-27, 2018 | Rome, Italy

Guidelines

International Biotechnology and Research Conference (Biotech-2018) is an annual conference which is one of the largest educational and scientific events in the Biotechnology community. This conference is going to be held from April 25-27, 2018 in Rome, Italy. The program is well designed by the conference committee which will have a variety of lectures from eminent scientists, oral sessions, poster presentations and symposia/workshops.

Target Audience:

  1. Medical Biotechnologists
  2. Pharmaceutical Biotechnologists
  3. Healthcare Biotechnologists
  4. Industrial Biotechnologists
  5. Biotechnology researchers and scholars
  6. Laboratory scientists

Abstract Submission Guidelines:

  1. Title of the abstract must be in sentence case. The title must represent the abstract content.
  2. Name of the author and co-authors (if present). You may list up to 20 individual authors for each abstract.
  3. Provide your full name, degree, institution, address, telephone number, and email address. (Email address of the main author/presenter).
  4. Abstract content must not exceed 300 words. The body of the abstract should describe your research, results and conclusions of your study.
  5. A short biography of 100 words of the main author/presenter must be included along with abstract.
  6. All the abstracts must be submitted before the deadlines provided.
  7. Abstract will be reviewed by the committee and you will receive an e-mail notification within 24-48 hours of abstract submission.

For the sample template of the abstract, please click here

Biotech-2018 Abstract Submission starts from July 02, 2017. All the abstracts should be submitted through online abstract submission or can be mailed at biotech@madridge.com

Tags

  • Submit Abstract Register Guidelines Program Brochure
  • Join our Mailing List


    © Copyrights 2017. www.madridge.org, CC-By This work is licensed under a Creative Commons Attribution 4.0 International License.